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OBJECTIVE — To determine the mortality rate after diabetes-related lower-extremity ampu-
tation (LEA) in an African-descent Caribbean population.
RESEARCH DESIGN AND METHODS — We conducted a prospective case-control
study. We recruited case subjects (with diabetes and LEA) and age-matched control subjects
(with diabetes and no LEA) between 1999 and 2001. We followed these groups for 5 years to
assess mortality risk and causes.
RESULTS — There were 205 amputations (123 minor and 82 major). The 1-year and 5-year
survival rates were 69 and 44% among case subjects and 97 and 82% among control subjects
(case-control difference, P  0.001). The mortality rates (per 1,000 person-years) were 273.9
(95% CI 207.1–362.3) after a major amputation, 113.4 (85.2–150.9) after a minor amputation,
and36.4(25.6–51.8)amongcontrolsubjects.Sepsisandcardiacdiseasewerethemostcommon
causes of death.
CONCLUSIONS — These mortality rates are the highest reported worldwide. Interventions
to limit sepsis and complications from cardiac disease offer a huge potential for improving
post-LEA survival in this vulnerable group.
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T
he diabetic foot syndrome, includ-
ing lower-extremity amputation
(LEA), is a major contributor to
morbidity and mortality from diabetes in
developed countries (1). There are lim-
ited outcome data from the developing
world (2). High incidence of type 2 dia-
betesisreportedintheCaribbean(3),and
the incidence of diabetes-related LEA in
Barbados ranks among the highest re-
ported in the world (4).
RESEARCH DESIGN AND
METHODS— The Barbados studies
of amputation among people with diabe-
tes proceeded in three stages. An initial
amputation incidence study recruited
participants undergoing LEA in the 12-
month period starting in November
1999. We deﬁned an amputation as mi-
nor if it involved the toes or foot and as
major if it was through the tibia or femur.
We further divided major amputations
into below-the-knee amputations (BKAs)
or above-the-knee amputations (AKAs).
We then recruited one randomly selected
population-based control group for every
case to initiate a case-control study of risk
factors for diabetes-related LEA. Control
subjects had diabetes, had never had an
amputation, and were age matched in
5-year age-groups. We restricted analyses
to participants who reported their race as
black(205caseand194controlsubjects).
A detailed description of methods, along
with LEA incidence and risk factors, has
been previously published (4). The fol-
low-up via telephone interviews contin-
ued until July 2007 to assess 5-year
survival. We conﬁrmed all reported
deaths using ofﬁcial records. For those
whohaddied,wecollectedcauseofdeath
from death certiﬁcates to report all-cause
mortality. The study received ethics ap-
proval,andallparticipants(ortheirprox-
ies) gave informed consent for baseline
and follow-up studies.
Statistical methods
We calculated survival using the Kaplan-
Meier analysis with stratiﬁcation by am-
putation status (AKA, BKA, minor
amputation, and control subjects). We
calculated all-cause mortality rates per
1,000 person-years using the same group
stratiﬁcation and adjusting for age using a
Poisson regression model accounting for
censored data. We compared these rates
using mortality rate ratios from our re-
gression model, with all analyses per-
formed using Stata (Release 10;
StataCorp, College Station, TX).
RESULTS— There were 123 (60%)
minor amputations, 47 (23%) BKAs, and
35 (17%) AKAs. Case and control sub-
jects were similarly age matched as a re-
sult of the study design (case subjects
70.5years[interquartilerange12.8],con-
trol subjects 69.3 years [12.2]; P  0.34).
Case subjects with a minor amputation
wereyoungerthanthosewithamajoram-
putation (minor LEA 67.1 years [13.2],
major LEA 75.7 years [10.3]; P  0.001),
and we controlled for this age difference
by presenting age-adjusted mortality
rates. The average diabetes duration for
case and control subjects was 17.8 years
(interquartile range 11.2) and 11.8 years
(9.8), respectively (P  0.001), with no
difference between those with minor and
major LEAs (P  0.35). There were mar-
ginally more male case subjects than con-
trol subjects (44.9 vs. 34.5%; P  0.04).
Case subjects were more likely than con-
trolsubjectstohavepoorerglycemiccon-
trol(GHb11.1vs.9.1%,respectively;P
0.001).
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LEA, there were 145 deaths (112 ampu-
tees and 33 control subjects). Figure 1
presents the survival experience among
case and control subjects and highlights
the low survival rate after a major ampu-
tation. Survival rates at 3 months, 6
months, 1 year, and 5 years after an AKA
were 51, 49, 34, and 10%, respectively,
andafteraBKAwere68,64,60,and28%.
Survival rates after a minor amputation
were 92, 86, 81, and 59%. Overall sur-
vival rates among case subjects were 80,
75, 69, and 44% and among control sub-
jects were 100, 99, 97, and 82%.
Age-adjusted all-cause mortality rates
per 1,000 person-years were 432.0 (95%
CI 294.7–633.1) after an AKA, 205.9
(142.8–296.8) after a BKA, 273.9
(207.1–362.3) after a major amputation,
113.4 (85.2–150.9) after a minor ampu-
tation, and 36.4 (25.6–51.8) among con-
trol subjects. All-cause mortality after any
amputation was 162.6/1,000 person-
years(132.1–200.1).Mortalityafterama-
jor LEA was over seven times higher than
that in control subjects (rate ratio 7.59
[4.97–11.58]; P  0.001) and over twice
that for minor LEAs (2.43 [1.66–3.55];
P  0.001). The minor LEA rate was over
three times higher than that for control
subjects (3.12 [2.01–4.86]; P  0.001).
Overall, mortality among case subjects
was almost ﬁve times that of control sub-
jects (4.68 [3.17–6.90]; P  0.001).
Wecouldnotascertaincauseofdeath
in 5 of 145 (3%) subjects (3 with major
amputations and 2 control subjects).
Among 181 recorded causes of death, the
5principalcausesincaseandcontrolsub-
jects, respectively, were sepsis (49 and
27%), cardiac disease (45 and 25%),
stroke (18 and 10%), pneumonia (17 and
9%), and renal problems (14 and 8%).
There were no statistically signiﬁcant dif-
ferences in the proportion of case and
control subjects dying from each cause
(P  0.05 for each cause of death).
CONCLUSIONS— This study docu-
ments, for the ﬁrst time, mortality associ-
ated with diabetes-related LEA in the
Caribbean. Mortality rates were above
those from other studied populations
(2,5).Inparticular,theall-causemortality
rate after a BKA among another high-risk
group, American Indians in North
America, was reported as 143.7/1,000
person-years—compared with 205.9/
1,000 person-years following a BKA in
our population.
Cardiovascular disease is the princi-
pal cause of death following diabetes-
related amputation in the developed
world (5). In this population, sepsis and
cardiac disease contributed to a similar
number of deaths, as they did in a single
study from West Africa (6), which sug-
gests the possibility of a different hierar-
chy of postamputation complications in
the developing world. Such differences
maybeunderpinnedbyhealthcareaccess
and social inﬂuences, including footwear
choices (4,7).
Patient factors and health care system
inadequacies may contribute to the bur-
denofdiabetes-relatedcomplications.Ef-
fective solutions to reduce the burden of
amputationhavebeensuccessfullyimple-
mented in other settings (8). Improve-
ment is required in simple techniques for
optimizing glycemic control, preventing
and detecting foot complications, manag-
ing wounds and ulcers, and providing
postamputation support services.
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